Market Tracker

07/24 6:26am ET

Orexigen Therapeutics Inc (NASDAQ:OREX)

5.34
Data as of Jul 23
 +0.05 / +0.95%
Today’s Change
4.60
Today|||52-Week Range
7.84
-5.15%
Year-to-Date

Today’s Trading

Previous close5.29
Today’s open5.33
Day’s range-- - --
Volume2,796,420
Average volume (3 months)3,441,451
Market cap$615.4M
Dividend yield--
Data as of 07/23/2014

Growth & Valuation

Earnings growth (last year)+37.01%
Earnings growth (this year)+115.42%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales158.47
Price/Book13.26

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...0.000.00%
NLNKNewLink Genetics Cor...0.000.00%
VTLVital Therapies Inc-1.70-6.36%
OMEDOncoMed Pharmaceutic...+2.18+9.93%
Data as of 07/23/2014

Financials

Next reporting dateAugust 5, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$3.4M
Annual profit (last year)-$77.7M
Net profit margin-2,265.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts